Medicina
Département
Centre Hospitalier Regional et Universitaire de Lille
Lila, FranciaPublications en collaboration avec des chercheurs de Centre Hospitalier Regional et Universitaire de Lille (72)
2024
-
Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023
Transplant Infectious Disease, Vol. 26, Núm. 1
2023
-
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy
Transplantation and Cellular Therapy, Vol. 29, Núm. 7, pp. 430-437
-
COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure
Clinical Nutrition ESPEN, Vol. 55, pp. 212-220
-
Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses
European heart journal. Quality of care & clinical outcomes, Vol. 9, Núm. 2, pp. 194-202
-
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
Nature Medicine, Vol. 29, Núm. 9, pp. 2259-2267
-
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG
Critical Care, Vol. 27, Núm. 1
2022
-
Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study
The American journal of gastroenterology, Vol. 117, Núm. 5, pp. 818
-
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Scientific Data, Vol. 9, Núm. 1
-
One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial
Circulation
-
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1736-1750
-
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
New England Journal of Medicine, Vol. 386, Núm. 7, pp. 629-639
-
The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study
American Journal of Gastroenterology, Vol. 117, Núm. 2, pp. 301-310
2021
-
Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey
Clinical Nutrition ESPEN, Vol. 45, pp. 433-441
-
Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events among Patients with Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial
JAMA - Journal of the American Medical Association, Vol. 325, Núm. 6, pp. 552-560
-
Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study
Journal of Psychosomatic Research, Vol. 140
-
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study
Journal of Hepatology, Vol. 75, Núm. 5, pp. 1026-1033
-
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
The Lancet, Vol. 397, Núm. 10292, pp. 2361-2371
-
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis
Bone Marrow Transplantation, Vol. 56, Núm. 9, pp. 2160-2172
-
Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real-life data from a multicentre retrospective study
Transplant Infectious Disease, Vol. 23, Núm. 4
2020
-
First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Clinical Cancer Research, Vol. 26, Núm. 10, pp. 2308-2317